Perrigo Company plc Unrealized Gain (Loss) on Investments
Perrigo Company plc (PRGO) reported Unrealized Gain (Loss) on Investments of $8.70 million for the 12-month period ending 2016-12-31, per its 10-K filed 2019-02-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2019-02-27
- Perrigo Company plc unrealized gain (loss) on investments for the quarter ending 2016-12-31 was $0.00.
- Perrigo Company plc unrealized gain (loss) on investments for the quarter ending 2016-10-01 was $0.00.
- Perrigo Company plc unrealized gain (loss) on investments for the quarter ending 2016-07-02 was $8.70M.
- Perrigo Company plc unrealized gain (loss) on investments for the quarter ending 2016-04-02 was $8.70M.
- Perrigo Company plc unrealized gain (loss) on investments for fiscal 2016 was $8.70M.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $0.00 derived: sum of 2 quarters · filed 2019-02-27 | $8.70M derived: sum of 3 quarters · filed 2019-02-27 | $8.70M 10-K · filed 2019-02-27 |
| 2016-10-01 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2017-11-09 | $8.70M derived: sum of 2 quarters · filed 2017-11-09 | $8.70M 10-Q · filed 2017-11-09 | |
| 2016-07-02 | $8.70M 10-Q · filed 2017-08-10 | $8.70M 10-Q/A · filed 2017-05-22 | ||
| 2016-04-02 | $8.70M 10-Q · filed 2017-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |